Boston, Mass./Lake Oswego, Ore. – May 14, 2009 – BIOTRONIK, Inc. announced that the REPLACE registry results were presented today at Heart Rhythm 2009 during the Late Breaking Clinical Trials session. The REPLACE Registry is a multi-center trial designed to provide physicians the data they need in advising patients and deciding on replacement of cardiac rhythm management devices.
Select the PDF icon to the left to view and download the presentation.
As one of the world’s leading cardiovascular medical device companies, with several million implanted devices, BIOTRONIK is represented in over 100 countries with its global workforce of more than 4,500 employees. Known for having its finger on the pulse of the medical community, BIOTRONIK assesses the challenges physicians face, and provides the best solutions for all phases of patient care, ranging from diagnosis to treatment to patient management. Quality, innovation and reliability define BIOTRONIK and its growing success, and deliver confidence and peace of mind to physicians and their patients worldwide.